BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Neuren Pharmaceuticals Limited 

Level 3
2-6 Park Avenue
Grafton  Auckland    New Zealand
Phone: 64-9-367-7167, Ext 82308 Fax: 64-9-367-7186


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Neuren Pharmaceuticals Limited Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs 8/10/2012 9:51:31 AM    More...
Noble Life Sciences Inc. Announces Collaboration With Perseis Therapeutics -- Noble to Manage Neuren Pharmaceuticals Limited Subsidiary's Oncology Program 7/10/2012 8:19:55 AM    More...
Neuren Pharmaceuticals Limited Holds Pre-IND Meeting on Proposed Rett Syndrome Clinical Trials With FDA 5/17/2012 8:21:22 AM    More...
Neuren Pharmaceuticals Limited To Get US$5.5M Additional Funding for US Army Clinical Trial of NNZ-2566 9/5/2008 9:44:14 AM    More...
Neuren Pharmaceuticals Limited Announce Glypromate(R) and NNZ-2566 Included in 10 Most Promising Neuroscience Projects by Windhover Information Inc. 7/21/2008 9:21:31 AM    More...
Neuren Pharmaceuticals Limited Raises A$7.1M in Rights Issue 2/11/2008 12:07:00 PM    More...
US Department of Defense Approves Funding for Neuren Pharmaceuticals Limited NNZ-2566 Trials 1/21/2008 11:16:20 AM    More...
Neuren Pharmaceuticals Limited Announces A$10.1 Million Non-Renounceable Rights Issue 12/19/2007 10:34:21 AM    More...
Neuren Pharmaceuticals Limited Completes NNZ-2566 Phase 1b Safety Trial 11/7/2007 2:07:20 PM    More...
Neuren Pharmaceuticals Limited in First Phase 3 Trial in Australia 9/26/2007 1:16:07 PM    More...
1234

//-->